Skip to Content

WARRICK 1670 (Theophylline extended-release 300 mg)

Pill imprint WARRICK 1670 has been identified as Theophylline extended-release 300 mg.

Theophylline is used in the treatment of asthma, maintenance; asthma, acute; apnea of prematurity and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Theophylline extended-release 300 mg WARRICK 1670
Theophylline extended-release 300 mg WARRICK 1670  Front
Theophylline extended-release 300 mg WARRICK 1670  Back
Discount Card Promo
Theophylline extended-release
Imprint:
WARRICK 1670
Strength:
300 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Methylxanthines
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Warrick Pharmaceuticals Corporation

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide